Who to call at Caravel Bio, and when
Fundz watches for the moments Caravel Bio starts buying, and tells you who to reach.
- An alert the day Caravel Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Caravel Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Caravel Bio. With Fundz connected, it knows.
Caravel Bio secures $1.2M NSF Phase II grant to advance biomolecular engineering platform for protein design with new-to-nature chemistries.
PortlandBiotechnologyDescription
Caravel Bio, a Portland, OR-based biomolecular engineering platform provider, received a $1.2M NSF Phase II grant. The funds will support development of a system for creating and scaling proteins with new-to-nature chemistries, scaling machine learning datasets, and extending the platform to additional enzyme classes. The company will execute real-world pilots for customers in DNA writing, carbon capture, and rare earth separations. Caravel Bio's platform combines cell-free protein synthesis, microfluidic droplets, and bacterial spore display to enable discovery and design of novel proteins.
Quick answer
Caravel Bio secures $1.2M NSF Phase II grant to advance biomolecular engineering platform for protein design with new-to-nature chemistries. (November 4, 2026). Caravel Bio is based in Portland, Oregon, United States.
- What agreement did Caravel Bio announce on November 4, 2026?
- Caravel Bio, a Portland, OR-based biomolecular engineering platform provider, received a $1.2M NSF Phase II grant. The funds will support development of a system for creating and scaling proteins with new-to-nature chemistries, scaling machine learning datasets, and extending the platform to additional enzyme classes.
- What does Caravel Bio do?
- Caravel Bio is a Portland, OR-based provider of a biomolecular engineering and protein design platform that combines cell-free protein synthesis, microfluidic droplets, and bacterial spore display.
- Where is Caravel Bio based?
- Caravel Bio is based in Portland, Oregon, United States.
- Which similar companies announced agreements around the same time?
- JD Technologies Global (November 4, 2026), Nxera Pharma (November 4, 2026), Evommune (November 4, 2026) and VIVA In Vitro Diagnostics (November 4, 2026) also announced agreements within 45 days of Caravel Bio.
Source: Fundz verified event record.
Other recent agreements in Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- JD Technologies Global and FRIWO North America Form Strategic Partnership to Enhance U.S. Medical Market Access (November 4, 2026)
- AbbVie secures exclusive licensing rights to Nxera’s EP4 program for inflammatory bowel disease with a $100 million payment. (November 4, 2026)
- Evommune Enters Exclusive License Agreement with Hinova Pharmaceuticals (November 4, 2026)
- VIVA In Vitro Diagnostics and ASKA Biotech Form Strategic Partnership to Enhance VIVA-ELISA® Manufacturing. (November 4, 2026)
- Wildcat Defense partners with Taqtile to deploy digital tools in shipyards. (November 4, 2026)
- Physiomics Wins New Contract for Drug Development Modelling Services (November 4, 2026)
Caravel Bio signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.